agree that management should use this quiet opportunity to provide some guidance and even pump the stock a little. They are not doing their job. As a share holder, do we have voting rights on their share printing? Bonuses should only be given on accomplishments for the company and share holders. The scientists in the background got Afrezza approved, not this group of lazy management.
I vote not to give themselves any more free shares.
best disguise ever, that's what they want you to believe. You bit the bait. They couldn't do the share dilution because Sanofi would have to pay alot more for share conversion. Think about that for a second before you negate this possibility. Assume they dilute instead of announcing this fake partnership? Let's say they dilute 100 mil shares more at $10/sh, that means Sanofi has to pay off the extra 100 mil shares, a lot more expensive.
had you followed my theory on why the stock price is trading 40% off today is because insiders had to cover their hedged positions; this works well in alllowing Sanofi to accumulate cheap shares, before swapping. Hence the buyout price for Sanofi isn't going to be $22 bil (1:1 share tradeoff), it will be much lower depending on how many shares Sanofi can accumulate. Imagine if they accumulate 50 mil shares are 6-9, then trade that off at 50; they will have saved $2 bil. Does Al Mann care? Of course not, he still owns all his shares.
what makes your theory work is that it is a perfect disguise because the price drop to the current level is what insiders want in order to momentarily cover their hedged positions, concurrently this is what Sanofi wants in order to accumulate cheap shares before the swapping. Even if there was a leak in buyout, there have been greater forces wanting the price down momentarily, hence, tradings do not depict such buyout price.
The shorts on the other hand, being stupid as they have always been, see the $150 mil upfront payment as an opportunity to short more or not cover. Until they get blindsided.
Although theory, yours and mine tie up together really well, and both of our theories work out well for all insiders. The only ones clueless in this case are the complacent shorts. WE will see by Novemember.
look at my full support of mnkd historic posts, shorts are in grave danger of going bankrupt. Shares are running dry and they have 72 mil to cover. This will shoot to $20 in a snap; they know it and they try and try to get this lower in this quiet period.
they know that game will be over for them once advertisement hits the airway during the holiday season. Afrezza will go viral and technosphere will be the platform that every big pharma will look into.
a few trading days in which millions of shares traded in pre-market, that was how the insiders where able to cover 5 mil shares. They sold shares to themselves!!!!
. The 5 mil shares which was covered from the period of August 15th- 30th was most likely insiders coverage which they hedge against their share ownership during FDA decision. Notice how insiders sold half of shares recently issued to themselves in NON-open market (most likely sold shares to themselves to cover hedged positions). The real shorts are fkked, they can't cover! There are no shares left to cover, trading is as dry as California drought.
LOngs, buy all you can afford, pressure these short mthfkkers to a massive squeeze. Afrezza and technosphere is bigger than any drug.
Now I can say, I have seen it all. My theory is that management had to hedge to protect their shares against the FDA who had screwed them many times before. That is the reason of this huge price drop and silence for the last 2 months since approval, along with short manipulation. But I think insiders are finished covering their hedge positions and now at the turning point of a reversal, with Al Mann speaking to defend the company for the first time in 2 months.
first time in 2 months since FDA/parntership, management finally said something positive about the company. Now do you doubt my theory? They had to hedge their position during the FDA decision; they couldn't have put all their investments in the hands of FDA crooks.
Now that they are done covering their hedge positions, good times are ahead; I am sure the banks that they had talks with were all behind this. They had 2 months to accumulate cheap shares, now they will bring this up to 20 where it should have been after partner and FDA.
Something to look forward to in the next month or two: Al Mann advertising on 60 mins, CNBC Mad Money, Talk shows, Sanofi TV commercial on Afrezza, Sanofi ads
after 2 months, management finally spoke; they are out of the silence. I think they are done covering their hedged positions facing the FDA, now resuming the rally to the $20's where it should have headed after FDA/partnership.
Time's Magazine title: Mann of the year in 2015. Share price will be $75
first sign that management is actually doing their job, first advertisement from Alfred Mann. I think it took them 2 months to finally covered their hedge positions, now they are starting to behave like management again. Let the good times roll, Al Mann on Crammer's Mad money, CNBC, 60 minutes, Time's mann of the year, Sanofi TV commericals, and other advertisements.
$240 billion market cost for diabetes, create a new pie for Afrezza that is worth $80 bil, cut down the other costs, the rest goes to long acting insulin and long acting pills.
I contacted Warren Buffet's Berkshire Hathaway and a few others. I hope they see value in this mega drug blockbuster and technosphere unlimited potential. I hope they will start some buying and short squeeze soon.
but please write to Berkshire Hathaway. I did my part to let the big boys know about the market potential and technosphere numerous applications. Carl Incahn, will be next.....I am contacting all the big boys.
Mr. Buffet is a humanitarian as much as an investor. I am sure he will understand the situation that Alfred Mann is in; and mankind stock is being attacked by short hedge fund managers.